Stem cells from the eye hold a great potential for vision restoration and can also be used for regeneration in other tissues. In this study, we characterized the stem cell properties of Trabecular meshwork stem cells (TMSCs) after long-term cryopreservation (∼8 years). TMSCs derived from four donors were examined for their viability and proliferation, as well as stem cell marker expression. Spheroid formation, colony formation, and multipotency were investigated. We observed that TMSCs were fully viable with variable proliferation ability. They expressed the stem cell markers CD90, CD166, CD105, CD73, OCT4, SSEA4, Notch1, KLF4, ABCG2, Nestin, and HNK1 detected by flow cytometry, quantitative polymerase chain reaction, or immunofluorescent staining. They could form spheroids and colonies after thawing. All TMSCs were able to differentiate into osteocytes, neural cells, and trabecular meshwork (TM) cells, but not adipocytes. Differentiated TM cells responded to dexamethasone treatment with increased expression of myocilin and angiopoietin-like 7 (ANGPTL7). In a nutshell, our study demonstrated that TMSCs retain their stem cell properties after long-term cryopreservation and hence can be an effective cell therapy source for various clinical applications.
Get full access to this article
View all access options for this article.
References
1.
WeinrebRN, AungT and MedeirosFA. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 311:1901–1911.
2.
QuigleyHA, AddicksEM, GreenWR and MaumeneeAE. (1981). Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol, 99:635–649.
3.
BurgoyneCF, DownsJC, BellezzaAJ, SuhJK and HartRT. (2005). The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res, 24:39–73.
4.
AlvaradoJ, MurphyC and JusterR. (1984). Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology, 91:564–579.
5.
HamardP, ValtotF, SourdilleP, Bourles-DagonetF and BaudouinC. (2002). Confocal microscopic examination of trabecular meshwork removed during ab externo trabeculectomy. Br J Ophthalmol, 86:1046–1052.
6.
RasmussenCA and KaufmanPL. (2014). The trabecular meshwork in normal eyes and in exfoliation glaucoma. J Glaucoma, 23:S15–S19.
7.
SaloweRJ and O'BrienJM. (2014). NEI's audacious goals initiative. Ophthalmology, 121:615–616.
8.
BangOY. (2016). Clinical trials of adult stem cell therapy in patients with ischemic stroke. J Clin Neurol, 12:14–20.
9.
ProckopDJ and OlsonSD. (2007). Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood, 109:3147–3151.
10.
DuY, RohDS, MannMM, FunderburghML, FunderburghJL and SchumanJS. (2012). Multipotent stem cells from trabecular meshwork become phagocytic TM cells. Invest Ophthalmol Vis Sci, 53:1566–1575.
11.
YunH, ZhouY, WillsA and DuY. (2016). Stem cells in the trabecular meshwork for regulating intraocular pressure. J Ocul Pharmacol Ther, 32:253–260.
12.
DuY, YunH, YangE and SchumanJS. (2013). Stem cells from trabecular meshwork home to TM tissue in vivo. Invest Ophthalmol Vis Sci, 54:1450–1459.
13.
YunH, WangY, ZhouY, WangK, SunM, StolzDB, XiaX, EthierCR and DuY. (2018). Human stem cells home to and repair laser-damaged trabecular meshwork in a mouse model. Commun Biol, 1:216.
14.
YuWY, SheridanC, GriersonI, MasonS, KearnsV, LoAC and WongD. (2011). Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma. J Biomed Biotechnol, 2011:412743.
15.
KimH, KimHY, ChoiMR, HwangS, NamKH, KimHC, HanJS, KimKS, YoonHS and KimSH. (2010). Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett, 468:190–194.
16.
MendicinoM, BaileyAM, WonnacottK, PuriRK and BauerSR. (2014). MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell, 14:141–145.
17.
GalipeauJ. (2013). The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy, 15:2–8.
18.
FrancoisM, CoplandIB, YuanS, Romieu-MourezR, WallerEK and GalipeauJ. (2012). Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy, 14:147–152.
19.
DuY, FunderburghML, MannMM, SundarRajN and FunderburghJL. (2005). Multipotent stem cells in human corneal stroma. Stem Cells, 23:1266–1275.
20.
KumarA, KumarV, RattanV, JhaV and BhattacharyyaS. (2017). Secretome cues modulate the neurogenic potential of bone marrow and dental stem cells. Mol Neurobiol, 54:4672–4682.
21.
KumarA, KumarV, RattanV, JhaV, PalA and BhattacharyyaS. (2017). Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue. Sci Rep, 7:15015.
22.
KellerKE, BhattacharyaSK, BorrasT, BrunnerTM, ChansangpetchS, ClarkAF, DismukeWM, DuY, ElliottMH, et al. (2018). Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. Exp Eye Res, 171:164–173.
23.
AbbottA. (2014). Leaked files slam stem-cell therapy. Nature, 505:139–140.
24.
KuriyanAE, AlbiniTA, TownsendJH, RodriguezM, PandyaHK, LeonardRE2nd, ParrottMB, RosenfeldPJ, FlynnHWJr. and GoldbergJL. (2017). Vision loss after intravitreal injection of autologous “stem cells” for AMD. N Engl J Med, 376:1047–1053.
25.
TrounsonA and McDonaldC. (2015). Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell, 17:11–22.
26.
ChambersDC, EneverD, IlicN, SparksL, WhitelawK, AyresJ, YerkovichST, KhalilD, AtkinsonKM and HopkinsPM. (2014). A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology, 19:1013–1018.
27.
GuptaN, HenryRG, StroberJ, KangSM, LimDA, BucciM, CaverzasiE, GaetanoL, MandelliML, et al. (2012). Neural stem cell engraftment and myelination in the human brain. Sci Transl Med, 4:155ra137.
28.
Le BlancK, FrassoniF, BallL, LocatelliF, RoelofsH, LewisI, LaninoE, SundbergB, BernardoME, et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet, 371:1579–1586.
29.
SachdevaN. (2009). Analysis of the viability of umbilical cord blood stem cells. J Stem Cells Regen Med, 5:44–48.
30.
MorgensternDA, AhsanG, BrocklesbyM, IngsS, BalsaC, VeysP, BrockP, AndersonJ, AmroliaP, et al. (2016). Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes. Br J Haematol, 174:942–951.
31.
KumarA, BhattacharyyaS and RattanV. (2015). Effect of uncontrolled freezing on biological characteristics of human dental pulp stem cells. Cell Tissue Bank, 16:513–522.
32.
KumarA, XuY, YangE and DuY. (2018). Stemness and regenerative potential of corneal stromal stem cells and their secretome after long-term storage: implications for ocular regeneration. Invest Ophthalmol Vis Sci, 59:3728–3738.
33.
LouisSA, RietzeRL, DeleyrolleL, WageyRE, ThomasTE, EavesAC and ReynoldsBA. (2008). Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells, 26:988–996.
34.
PastranaE, Silva-VargasV and DoetschF. (2011). Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell, 8:486–498.
35.
TayCY, SathiyanathanP, ChuSW, StantonLW and WongTT. (2012). Identification and characterization of mesenchymal stem cells derived from the trabecular meshwork of the human eye. Stem Cells Dev, 21:1381–1390.
36.
NadriS, YazdaniS, ArefianE, GohariZ, EslaminejadMB, KazemiB and SoleimaniM. (2013). Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane. Neurosci Lett, 541:43–48.
37.
KelleyMJ, RoseAY, KellerKE, HessleH, SamplesJR and AcottTS. (2009). Stem cells in the trabecular meshwork: present and future promises. Exp Eye Res, 88:747–751.
38.
McGowanSL, EdelhauserHF, PfisterRR and WhikehartDR. (2007). Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis, 13:1984–2000.
39.
BraungerBM, AdemogluB, KoschadeSE, FuchshoferR, GabeltBT, KilandJA, Hennes-BeannEA, BrunnerKG, KaufmanPL and TammER. (2014). Identification of adult stem cells in Schwalbe's line region of the primate eye. Invest Ophthalmol Vis Sci, 55:7499–7507.
40.
ZhangY, CaiS, TsengSCG and ZhuYT. (2018). Isolation and expansion of multipotent progenitors from human trabecular meshwork. Sci Rep, 8:2814.
41.
CastroA and DuY. (2019). Trabecular meshwork regeneration—a potential treatment for glaucoma. Curr Ophthalmol Rep, 7:80–88.
42.
FisherJN, PerettiGM and ScottiC. (2016). Stem cells for bone regeneration: from cell-based therapies to decellularised engineered extracellular matrices. Stem Cells Int, 2016:9352598.
43.
MorganJT, WoodJA, WalkerNJ, RaghunathanVK, BorjessonDL, MurphyCJ and RussellP. (2014). Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells. J Ocul Pharmacol Ther, 30:254–266.
44.
LunnJS, SakowskiSA, HurJ and FeldmanEL. (2011). Stem cell technology for neurodegenerative diseases. Ann Neurol, 70:353–361.
45.
YanJ, XuL, WelshAM, HatfieldG, HazelT, JoheK and KoliatsosVE. (2007). Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med, 4:e39.
46.
CortiS, NizzardoM, NardiniM, DonadoniC, SalaniS, RonchiD, SaladinoF, BordoniA, FortunatoF, et al. (2008). Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J Clin Invest, 118:3316–3330.
47.
FreemanTB, CicchettiF, Bachoud-LeviAC and DunnettSB. (2018). Technical factors that influence neural transplant safety in Huntington's disease. Exp Neurol, 227:1–9.
48.
WangH, WuM, ZhanC, MaE, YangM, YangX and LiY. (2012). Neurofilament proteins in axonal regeneration and neurodegenerative diseases. Neural Regen Res, 7:620–626.
49.
UchidaA, TashiroT, KomiyaY, YorifujiH, KishimotoT and HisanagaS. (2004). Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons. J Neurochem, 88:735–745.
50.
FoudahD, MonfriniM, DonzelliE, NiadaS, BriniAT, OrcianiM, TrediciG and MilosoM. (2014). Expression of neural markers by undifferentiated mesenchymal-like stem cells from different sources. J Immunol Res, 2014:987678.
51.
SathiyanathanP, TayCY and StantonLW. (2017). Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation. BMC Genomics, 18:383.
52.
StamerWD, SeftorRE, SnyderRW and ReganJW. (1995). Cultured human trabecular meshwork cells express aquaporin-1 water channels. Curr Eye Res, 14:1095–1100.
53.
StamerWD, PeppelK, O'DonnellME, RobertsBC, WuF and EpsteinDL. (2001). Expression of aquaporin-1 in human trabecular meshwork cells: role in resting cell volume. Invest Ophthalmol Vis Sci, 42:1803–1811.
54.
WangY, OsakueD, YangE, ZhouY, GongH, XiaX and DuY. (2019). Endoplasmic reticulum stress response of trabecular meshwork stem cells and trabecular meshwork cells and protective effects of activated PERK pathway. Invest Ophthalmol Vis Sci, 60:265–273.
55.
RaghunathanVK, MorganJT, ParkSA, WeberD, PhinneyBS, MurphyCJ and RussellP. (2015). Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix. Invest Ophthalmol Vis Sci, 56:4447–4459.
56.
RussellP and JohnsonM. (2012). Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci, 53:117.
57.
KuchteyJ, KallbergME, GelattKN, RinkoskiT, KomaromyAM and KuchteyRW. (2008). Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci, 49:3438–3448.
58.
ComesN, BuieLK and BorrasT. (2011). Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma. Genes Cells, 16:243–259.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
